Avacta and Daewoong Pharmaceutical have announced a collaboration to develop the next generation of cell and gene therapies incorporating Affimer proteins to enhance the immune-modulatory effects.

Absolute Antibody has announced the launch of its VivopureX™ recombinant mouse antibodies for in vivo research in mouse models.

Expedeon shareholders have approved the sale of its proteomics and immunology business, as well as the proposed name change to 4basebio AG, reflecting the Company’s future focus on DNA manufacturing for gene therapy and gene vaccines.

The National Institute of Allergy and Infectious Diseases (NIAID) has announced the establishment of the Infectious Diseases Clinical Research Consortium, a clinical trials network that will encompass the Institute’s long-standing Vaccine and Treatment Evaluation Units (VTEUs) and create a new consortium leadership group.

The Pistoia Alliance has announced the publication of a new report into the future of the life science and healthcare industries: ‘2030: Life sciences and Health in the Digital Age’.

Porvair Filtration Group has announced an expansion to its range of microfiltration products by launching seven new filters for use within process air and gas applications.

Sartorius has announced that it has established a Scientific Advisory Board for its Corporate Research activities.

Newcells Biotech has announced that they have been awarded further funding to continue development of their model of the human liver, designed for the routine assessment of Yellow Fever vaccine attenuation.

Abcam and SomaServe have announced a partnership to commercialize the cell delivery potential of the polymer-based “bionic”’ nanoparticles, which can carry a range of payloads directly to live cells.

Until January 15, 2020, researchers up to 35 years, with an advanced degree, who are working in Europe are invited to apply online for the Eppendorf Award for Young European Investigators 2020.